ZURICH – September 15, 2026 -- IBM and Lockheed Martin have established a quantum innovation hub at ETH Zurich under an offset agreement with armasuisse, Switzerland's Federal Office for Defence Procurement, bringing the country its first IBM Quantum System Two.

Mainz – September 13, 2026 -- German broadcaster ZDF and Swiss broadcaster SRF launched a new international leadership forum, the Streamium Days, bringing executives from public and private media companies across Europe together at ZDF's Mainz headquarters on September 7-8, 2026.

Zug, Switzerland – September 12, 2026 -- KENDRIS, the Swiss-based advisory and fiduciary group, has secured a license from Luxembourg's Ordre des Experts-Comptables (OEC), allowing its local subsidiary to offer an expanded suite of regulated services including domiciliation, accounting and tax.

Lugano – – September 11, 2026 -- Fuze Finance has secured approval from the Supervisory Organisation for Financial Intermediaries and Trustees (SO-FIT) to operate as a supervised financial intermediary in Switzerland, marking the regulated crypto-assets infrastructure provider's first move into Western Europe. The approval, granted under the Anti-Money Laundering Act, allows Fuze to offer institutional clients crypto-asset infrastructure and stablecoin settlement alongside SWIFT, SEPA and SIC payment rails.

Berlin – September 08, 2026 -- PLAN-B NET ZERO AG and river-cleanup company everwave have tied clean-energy subscriptions directly to plastic removal, letting customers convert monthly add-on payments into a fixed volume of waste extracted from rivers before it reaches the ocean.

Schlieren – September 07, 2026 -- NovaGo Therapeutics AG has closed a Series B financing round of CHF 24 million ($30 million), led by Neurimmune and Pureos, to fund a proof-of-concept trial for its anti-Nogo-A antibody in acute spinal cord injury.

The equity round drew participation from existing and new investors and was supplemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life.

CHAM, Switzerland -- August 31, 2026 -- EYKON officially unveiled its new brand today, completing a separation from Landis+Gyr EMEA and establishing itself as an independent utility infrastructure technology company serving more than 75 markets.

The Swiss-based firm now supports over 100 million connected devices across the EMEA region, drawing on 130 years of utility-sector history rooted in Landis+Gyr's legacy operations.

CHAM, Switzerland -- -- EYKON unveiled its new corporate brand on Aug. 31, 2026, completing the separation of the former Landis+Gyr EMEA business into an independent utility infrastructure technology company. The Cham-based firm carries forward more than 130 years of Swiss utility engineering history under its new name. EYKON currently serves customers across more than 75 markets and supports over 100 million connected endpoints in the EMEA region.

Incheon, South Korea and Zug, Switzerland -- Samsung Biologics, through its Swiss subsidiary Samsung Peptide AG, published the formal tender offer prospectus for PolyPeptide Group AG, setting a cash price of CHF 44.31 per share and an implied equity value of approximately CHF 1.46 billion. The filing, made in Zug, Switzerland, follows a pre-announcement issued July 20, 2026, and covers all publicly held shares of the peptide-focused contract manufacturer listed on the SIX Swiss Exchange. The main acceptance period runs from Sept. 15 to Oct. 12, 2026.